Literature DB >> 8100781

Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter.

T Uchiumi1, K Kohno, H Tanimura, K Hidaka, K Asakuno, H Abe, Y Uchida, M Kuwano.   

Abstract

The human MDR1 gene can be induced in response to various environmental stimuli. To examine whether such stress-induced activation of the MDR1 gene can be modulated by protein kinase, we employed a stable human cancer KB cell line which contained the bacterial chloramphenicol acetyltransferase (CAT) gene directed by the MDR1 gene promoter. H-7, a protein kinase C inhibitor, at more than 40 microM inhibited activation of the MDR1 promoter that was induced by ethylmethane sulfonate, 5-fluorouracil or UV irradiation. DNA binding activity of nuclear factors recognizing the MDR1 promoter was augmented in KB cells treated with UV, but decreased in cells treated concomitantly with H-7. Okadaic acid alone was able to induce the promoter activation, and this induction was dependent on specific promoter sequences. Okadaic acid also enhanced the DNA binding activity of nuclear factors recognizing the MDR1 promoter. The phosphorylation of transacting factors may modulate the MDR1 gene promoter activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100781     DOI: 10.1016/0014-5793(93)81750-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.

Authors:  A Krautheim; P Brechlin; K Becker; M Winkler; H J Steinfelder
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 2.  Effects of phosphorylation of P-glycoprotein on multidrug resistance.

Authors:  U A Germann; T C Chambers; S V Ambudkar; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

Review 3.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

4.  Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.

Authors:  Valérie Gouazé-Andersson; Jing Y Yu; Adam J Kreitenberg; Alicja Bielawska; Armando E Giuliano; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2007-11-09

5.  Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.

Authors:  V Gekeler; J Beck; A Noller; A Wilisch; G Frese; M Neumann; R Handgretinger; G Ehninger; H Probst; D Niethammer
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

6.  Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.

Authors:  U Stein; W Walther; R H Shoemaker
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity.

Authors:  Maxim D Seferovic; Rashad Ali; Hiroyasu Kamei; Suya Liu; Javad M Khosravi; Steven Nazarian; Victor K M Han; Cunming Duan; Madhulika B Gupta
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

Review 8.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

9.  Cytokine-mediated reversal of multidrug resistance.

Authors:  U Stein; W Walther
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

10.  Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.

Authors:  J F Beck; D Brügger; K Brischwein; C Liu; P Bader; D Niethammer; V Gekeler
Journal:  Jpn J Cancer Res       Date:  2001-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.